Form 8-K - Current report:
SEC Accession No. 0001021771-25-000066
Filing Date
2025-03-27
Accepted
2025-03-27 16:11:19
Documents
18
Period of Report
2025-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FINANCIAL RESULTS YEAR ENDED DECEMBER 31, 2024 AND CONFERENCE CALL brt8k.htm   iXBRL 8-K 26074
5 PRESS RELEASE ex99_1.htm EX-99.1 1826
6 pr_1.jpg GRAPHIC 571572
7 pr_2.jpg GRAPHIC 486504
8 pr_3.jpg GRAPHIC 781910
9 pr_4.jpg GRAPHIC 106713
  Complete submission text file 0001021771-25-000066.txt   2843914

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA brtx-20250327.xsd EX-101.SCH 4000
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE brtx-20250327_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brtx-20250327_pre.xml EX-101.PRE 16056
20 EXTRACTED XBRL INSTANCE DOCUMENT brt8k_htm.xml XML 4058
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 25779380
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)